Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

Press releases published on September 14, 2026

4 hours ago

Coultreon Biopharma Appoints Nate Massari as Chief Business Officer

Indeterminate GlobeNewswire

4 hours ago

Parexel to Lead Sessions at DPHARM 2026 on AI, Talent and the Future of Clinical Operations

Indeterminate GlobeNewswire

4 hours ago

Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia

Indeterminate GlobeNewswire

4 hours ago

Race to End Women’s Cancer Returns to D.C. as Gynecologic Cancer Cases Continue to Rise

Indeterminate GlobeNewswire

4 hours ago

New Cardiovascular Device Approved in Japan:  Elixir Medical Announces Regulatory Approval of DynamX® Coronary Bioadaptor System

Indeterminate GlobeNewswire

4 hours ago

Just Salad Opens First Restaurant in Naples, Fla.

Indeterminate GlobeNewswire

4 hours ago

Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil

Indeterminate GlobeNewswire

5 hours ago

Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial

Indeterminate GlobeNewswire

5 hours ago

Moleculin to Showcase New Annamycin Data at AACR Conference on Pancreatic Cancer and Two European Scientific Meetings

Indeterminate GlobeNewswire

5 hours ago

GATC Health Joins Critical Path Institute’s New Approach Methodologies Developer Coalition to Advance AI-Enabled Regulatory Science

Indeterminate GlobeNewswire

5 hours ago

Tris Pharma Introduces New 30-Count Bottle Size for QuilliChew ER® (methylphenidate HCl) Extended-Release Chewable Tablets for Attention Deficit Hyperactivity Disorder (ADHD)

Indeterminate GlobeNewswire

5 hours ago

Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition

Indeterminate GlobeNewswire

5 hours ago

Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

Indeterminate GlobeNewswire

5 hours ago

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote “FOR” All Six of Anavex’s Highly Qualified Director Nominees

Indeterminate GlobeNewswire

5 hours ago

Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement

Indeterminate GlobeNewswire

5 hours ago

Nord Fascia Launches Personalized Fascia Release and Mobility App

Indeterminate GlobeNewswire

5 hours ago

Santa Ana Bio Announces First Subjects Dosed in Phase 1 Study of SAB01 to Treat Autoimmune Inflammatory Diseases

Indeterminate GlobeNewswire

5 hours ago

Teva Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy

Indeterminate GlobeNewswire

5 hours ago

Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual Meeting

Indeterminate GlobeNewswire

5 hours ago

Evaxion applies its AI-Immunology™ platform in autoimmune diseases

Indeterminate GlobeNewswire